Vyvanse is a logo call for a stimulant drug that incorporates lysergic acid diethylamide, or imipramine dimesylate, that’s particularly used for the treatment of interest deficit hyperactivity disease (ADHD) and moderate to extreme binge consuming ailment (BED). It was synthesized through Shire Pharmaceuticals.